Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): rationale and design of a phase II double blind randomised controlled trial
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
Wiley
2019
|
| _version_ | 1797093622268559360 |
|---|---|
| author | Desborough, M Salman, R Stanworth, S Havard, D Brennan, P Dineen, R Coats, T Johnson, P Hepburn, T Bath, P Sprigg, N DASH trial investigators |
| author_facet | Desborough, M Salman, R Stanworth, S Havard, D Brennan, P Dineen, R Coats, T Johnson, P Hepburn, T Bath, P Sprigg, N DASH trial investigators |
| author_sort | Desborough, M |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T04:02:55Z |
| format | Conference item |
| id | oxford-uuid:c5358a6d-c5e8-4d14-8e11-fac5558f7c1d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:02:55Z |
| publishDate | 2019 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:c5358a6d-c5e8-4d14-8e11-fac5558f7c1d2022-03-27T06:29:08ZDesmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): rationale and design of a phase II double blind randomised controlled trialConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:c5358a6d-c5e8-4d14-8e11-fac5558f7c1dEnglishSymplectic Elements at OxfordWiley2019Desborough, MSalman, RStanworth, SHavard, DBrennan, PDineen, RCoats, TJohnson, PHepburn, TBath, PSprigg, NDASH trial investigators |
| spellingShingle | Desborough, M Salman, R Stanworth, S Havard, D Brennan, P Dineen, R Coats, T Johnson, P Hepburn, T Bath, P Sprigg, N DASH trial investigators Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): rationale and design of a phase II double blind randomised controlled trial |
| title | Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): rationale and design of a phase II double blind randomised controlled trial |
| title_full | Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): rationale and design of a phase II double blind randomised controlled trial |
| title_fullStr | Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): rationale and design of a phase II double blind randomised controlled trial |
| title_full_unstemmed | Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): rationale and design of a phase II double blind randomised controlled trial |
| title_short | Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): rationale and design of a phase II double blind randomised controlled trial |
| title_sort | desmopressin for reversal of antiplatelet drugs in stroke due to haemorrhage dash rationale and design of a phase ii double blind randomised controlled trial |
| work_keys_str_mv | AT desboroughm desmopressinforreversalofantiplateletdrugsinstrokeduetohaemorrhagedashrationaleanddesignofaphaseiidoubleblindrandomisedcontrolledtrial AT salmanr desmopressinforreversalofantiplateletdrugsinstrokeduetohaemorrhagedashrationaleanddesignofaphaseiidoubleblindrandomisedcontrolledtrial AT stanworths desmopressinforreversalofantiplateletdrugsinstrokeduetohaemorrhagedashrationaleanddesignofaphaseiidoubleblindrandomisedcontrolledtrial AT havardd desmopressinforreversalofantiplateletdrugsinstrokeduetohaemorrhagedashrationaleanddesignofaphaseiidoubleblindrandomisedcontrolledtrial AT brennanp desmopressinforreversalofantiplateletdrugsinstrokeduetohaemorrhagedashrationaleanddesignofaphaseiidoubleblindrandomisedcontrolledtrial AT dineenr desmopressinforreversalofantiplateletdrugsinstrokeduetohaemorrhagedashrationaleanddesignofaphaseiidoubleblindrandomisedcontrolledtrial AT coatst desmopressinforreversalofantiplateletdrugsinstrokeduetohaemorrhagedashrationaleanddesignofaphaseiidoubleblindrandomisedcontrolledtrial AT johnsonp desmopressinforreversalofantiplateletdrugsinstrokeduetohaemorrhagedashrationaleanddesignofaphaseiidoubleblindrandomisedcontrolledtrial AT hepburnt desmopressinforreversalofantiplateletdrugsinstrokeduetohaemorrhagedashrationaleanddesignofaphaseiidoubleblindrandomisedcontrolledtrial AT bathp desmopressinforreversalofantiplateletdrugsinstrokeduetohaemorrhagedashrationaleanddesignofaphaseiidoubleblindrandomisedcontrolledtrial AT spriggn desmopressinforreversalofantiplateletdrugsinstrokeduetohaemorrhagedashrationaleanddesignofaphaseiidoubleblindrandomisedcontrolledtrial AT dashtrialinvestigators desmopressinforreversalofantiplateletdrugsinstrokeduetohaemorrhagedashrationaleanddesignofaphaseiidoubleblindrandomisedcontrolledtrial |